10.25384/SAGE.9089558.v1 Giuseppe Gullo Giuseppe Gullo Alex J. Eustace Alex J. Eustace Alexandra Canonici Alexandra Canonici Denis M. Collins Denis M. Collins Michael J. Kennedy Michael J. Kennedy Liam Grogan Liam Grogan Oscar Breathhnach Oscar Breathhnach John McCaffrey John McCaffrey Maccon Keane Maccon Keane Michael J. Martin Michael J. Martin Rajnish Gupta Rajnish Gupta Gregory Leonard Gregory Leonard Miriam O’Connor Miriam O’Connor Paula M. Calvert Paula M. Calvert Paul Donnellan Paul Donnellan Janice Walshe Janice Walshe Enda McDermott Enda McDermott Kathleen Scott Kathleen Scott Andres Hernando Andres Hernando Imelda Parker Imelda Parker David W. Murray David W. Murray Alice C. O’Farrell Alice C. O’Farrell Ashwini Maratha Ashwini Maratha Patrick Dicker Patrick Dicker Mairin Rafferty Mairin Rafferty Verena Murphy Verena Murphy Norma O’Donovan Norma O’Donovan William M. Gallagher William M. Gallagher Bonnie Ky Bonnie Ky Dimitrios Tryfonopoulos Dimitrios Tryfonopoulos Brian Moulton Brian Moulton Annette T. Byrne Annette T. Byrne John Crown John Crown Supplementary_Methods – Supplemental material for Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial SAGE Journals 2019 bevacizumab breast cancer cardiotoxicity biomarker docetaxel/cyclophosphamide 2019-07-25 12:08:06 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplementary_Methods_Supplemental_material_for_Pilot_study_of_bevacizumab_in_combination_with_docetaxel_and_cyclophosphamide_as_adjuvant_treatment_for_patients_with_early_stage_HER-2_negative_breast_cancer_including_analysis_of_candidate_c/9089558 <p>Supplemental material, Supplementary_Methods for Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial by Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici, Denis M. Collins, Michael J. Kennedy, Liam Grogan, Oscar Breathhnach, John McCaffrey, Maccon Keane, Michael J. Martin, Rajnish Gupta, Gregory Leonard, Miriam O’Connor, Paula M. Calvert, Paul Donnellan, Janice Walshe, Enda McDermott, Kathleen Scott, Andres Hernando, Imelda Parker, David W. Murray, Alice C. O’Farrell, Ashwini Maratha, Patrick Dicker, Mairin Rafferty, Verena Murphy, Norma O’Donovan, William M. Gallagher, Bonnie Ky, Dimitrios Tryfonopoulos, Brian Moulton, Annette T. Byrne and John Crown in Therapeutic Advances in Medical Oncology</p>